Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MEDLEYFRA:3YV +1.80%76 3-Year ROIIC % is 0.06 as of Dec. 2025, which is 99% below its 10-year median of 7.96. GuruFocus rates FRA:3YV with a GF Score™ of 76/100 and a GF Value™ of €36.65 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 619 Healthcare Providers & Services companies, MEDLEY ranks worse than 55.74% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
MEDLEY's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 0.06%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for MEDLEY's 3-Year ROIIC % or its related term are showing as below:
FRA:3YV's 3-Year ROIIC % is ranked worse than 55.74% of 619
companies
in the Healthcare Providers & Services industry
Industry Median: 3.46
vs FRA:3YV: 0.06
MEDLEY (FRA:3YV) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
MEDLEY 3-Year ROIIC % Related Terms
MEDLEY 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for MEDLEY's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:3YV vs VEEV, BTSG, TEM: 3-Year ROIIC % Comparison
For the Health Information Services subindustry, MEDLEY's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MEDLEY 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MEDLEY's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where MEDLEY's 3-Year ROIIC % falls into.
MEDLEY's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 4.8293376 (Dec. 2025) - 6.0510304 (Dec. 2022) )
/
( 190.014 (Dec. 2025) - 57.907 (Dec. 2022) )
=
-1.2216928
/
132.107
=
-0.92%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
MEDLEY (FRA:3YV) has a 3-Year ROIIC % of 0.06 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on MEDLEY and its competitors. This is 99% below median its historical median of 7.96. Over the past decade, MEDLEY's 3-Year ROIIC % has ranged from 0.06 to 20.47. According to the industry distribution chart, MEDLEY ranks #345 out of 619 companies in the Healthcare Providers & Services industry, placing it in the top 55.7%.
Is MEDLEY's 3-Year ROIIC % too high?
MEDLEY's current 3-Year ROIIC % of 0.06 is 99% below median its 10-year median of 7.96. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 20.47. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.46. MEDLEY's value of 0.06 is 98.3% below this industry median. Based on the distribution chart, MEDLEY ranks #345 out of 619 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, MEDLEY has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MEDLEY's 3-Year ROIIC % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MEDLEY ranks #345 out of 619 companies for 3-Year ROIIC %. This places MEDLEY in the lower half of its industry. The industry median 3-Year ROIIC % is 3.46. MEDLEY's value of 0.06 is 98.3% below this benchmark. Historically, MEDLEY's own 3-Year ROIIC % has ranged from 0.06 to 20.47 over the past decade. While the company's 10-year median is 7.96 vs. the industry median of 3.46, MEDLEY has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.46, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MEDLEY's current 3-Year ROIIC % of 0.06 is 98.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on MEDLEY and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MEDLEY's current 3-Year ROIIC % is 0.06, which is 99% below median its own 10-year median of 7.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDLEY stock overvalued right now?
Based on GuruFocus' analysis, MEDLEY (FRA:3YV) is currently considered Significantly Undervalued. The stock's GF Value™ is €36.65, compared to a current price of €11.30 — trading 69.2% below its estimated fair value. The current 3-Year ROIIC % is 0.06, which is 99% below median its 10-year median of 7.96 and 98.3% below the Healthcare Providers & Services industry median of 3.46. MEDLEY's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For MEDLEY (FRA:3YV), the current 3-Year ROIIC % is 0.06 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MEDLEY (FRA:3YV) Overvalued in 2026?
Based on GuruFocus' analysis, MEDLEY stock appears to be undervalued.
The current stock price of €11.30 is trading 69.2% below its estimated GF Value™ of €36.65.
GuruFocus considers MEDLEY to be Significantly Undervalued.
Key valuation signals for FRA:3YV:
3-Year ROIIC %: 0.06 (99% below median its 10-year median of 7.96)
GF Value™: €36.65 vs. price of €11.30 (69.2% below fair value)
Industry Position: 98.3% below the Healthcare Providers & Services median (#345 of 619)
No single metric tells the full story. See the FRA:3YV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MEDLEY Inc is engaged in providing medical information service for patients, and nursing care, a nursing care information service for citizens resolving issues in the field of medical healthcare. It provides its services through two platforms, Recruitment Platform Business which provides human resource recruitment systems in the medical and healthcare field and related businesses; and Medical Platform Business that is a telemedicine system for both patients and medical institutions.
76GF Score
Get the complete analysis for FRA:3YV
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3YV has been successfully added to your 
